 95% CI, 2.4-5.8;
P < .001) and higher 5-year freedom from recurrent
symptoms (OR, 4.4; 95% CI, 2.8-7.0; P < .001) despite no
difference in perioperative mortality or survival. Last,
Pecoraro et al112 (43 studies and 1795 patients) reported
lower